Hussman Strategic Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Hussman Strategic Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.27M	Buy	+5,250	New	+$3.57M	0.75%	32
2025 Q2	–	Sell	-2,100	Closed	-$1.33M	–	278
2025 Q1	$1.33M	Hold	2,100	–	–	0.32%	121
2024 Q4	$1.5M	Buy	+2,100	New	+$1.76M	0.44%	94
2024 Q2	–	Sell	-2,100	Closed	-$2.02M	–	245
2024 Q1	$2.02M	Sell	2,100 -2,100	-50%	-$2M	0.47%	85
2023 Q4	$3.69M	Hold	4,200	–	–	0.84%	25
2023 Q3	$3.46M	Sell	4,200 -3,600	-46%	-$2.83M	0.66%	34
2023 Q2	$5.6M	Hold	7,800	–	–	1.03%	8
2023 Q1	$6.41M	Hold	7,800	–	–	1.01%	5
2022 Q4	$5.63M	Sell	7,800 -1,500	-16%	-$1.11M	0.92%	11
2022 Q3	$6.41M	Sell	9,300 -1,050	-10%	-$661K	1.11%	6
2022 Q2	$6.12M	Buy	10,350 +4,110	+66%	+$2.67M	1.05%	10
2022 Q1	$4.36M	Buy	6,240 +1,040	+20%	+$658K	0.85%	13
2021 Q4	$3.28M	Buy	+5,200	New	+$3.2M	0.72%	22
2020 Q3	–	Sell	-4,100	Closed	-$2.56M	–	300
2020 Q2	$2.56M	Hold	4,100	–	–	0.65%	39
2020 Q1	$2M	Buy	4,100 +1,600	+64%	+$660K	0.54%	56
2019 Q4	$939K	Sell	2,500 -2,500	-50%	-$841K	0.3%	125
2019 Q3	$1.39M	Hold	5,000	–	–	0.39%	96
2019 Q2	$1.56M	Sell	5,000 -2,500	-33%	-$832K	0.44%	94
2019 Q1	$3.08M	Buy	+7,500	New	+$3.09M	0.75%	36

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hussman Strategic Advisors's REGN Position: Q2 2026 in Review

Hussman Strategic Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 5,250 shares worth $3.27M. The stake represents 0.75% of the portfolio and ranks #32 among its holdings. This is a return to the name: Hussman Strategic Advisors previously reported a position in REGN as recently as Q1 2025.

Hussman Strategic Advisors first reported a position in REGN in Q1 2019 and has held it in 19 quarters since. The position peaked at $6.41M in Q1 2023. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Hussman Strategic Advisors held 5,250 shares of Regeneron Pharmaceuticals worth $3.27M as of Q2 2026.
Regeneron Pharmaceuticals was a new Hussman Strategic Advisors position in Q2 2026.
Regeneron Pharmaceuticals made up 0.75% of Hussman Strategic Advisors's portfolio in Q2 2026, its #32 holding.
Hussman Strategic Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 19 quarters since.
Hussman Strategic Advisors's Regeneron Pharmaceuticals position peaked at $6.41M in Q1 2023.
1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.